Latest Capital Raisings News

Venari Minerals has lodged a prospectus for up to 8.14 million free options linked to its $6.1 million capital raising, with no immediate proceeds but almost $1 million possible if exercised. A separate 326,250-option allocation to directors now depends on fresh shareholder approval at the November AGM.

Cycliq’s customer receipts rose 21% in the September quarter, but the cycling technology company ended the period with just $382,000 in cash and less than two quarters of funding on its current burn rate. Its proposed $1.5 million placement remains partly dependent on shareholder approval.

N1 Holdings reported a sharp rise in first-quarter revenue and customer cash receipts, while expanding its accessible lending capacity to approximately $402 million. The growth came alongside a $5.39 million operating cash outflow and heightened scrutiny of Australia’s private credit sector.

C29 Metals ended September with $219,000 in cash and estimated funding for just 0.59 quarters, while its proposed $2.4 million placement remains subject to shareholder approval. The explorer reported no on-site exploration during the quarter, as it moved to cut costs and rationalise its portfolio.

Anatara Lifesciences narrowed its FY2026 loss and ended the year with A$470,917 in cash, but warned that further capital raising is included in its business plan and may be necessary to remain a going concern. Its AOC anti-obesity candidate produced statistically significant results in mice, while mechanism-of-action data remained inconclusive and development was placed on hold.

Reedy Lagoon has issued 1.44 billion shares at $0.00125 each, completing the shareholder-approved placement and injecting approximately $1.8 million before costs. The Section 708A notice clears the shares for trading without further disclosure, but the filing leaves the enlarged capital structure and use of funds unstated.

Orpheus Uranium has begun maiden drilling at its Frome Project while expanding its Marree landholding and raising $4.25 million to fund exploration. The quarter ended with $7.45 million in cash and liquid investments, but the company is still awaiting results and several transaction milestones.

dorsaVi has commercially launched its first wearable capable of analysing movement and delivering feedback directly on-device, while its RRAM chip program moves into fabrication and testing. The progress comes alongside a post-quarter A$3.0 million capital raising, against quarter-end cash of $1.12 million and operating cash outflow of about $996,000.

Alara Resources has reported its first full-year profit after its Oman copper operation produced above nameplate capacity, lifting revenue 145% to A$135.3 million. The turnaround is substantial, but negative operating cash flow and a planned A$6 million equity raise keep the balance sheet firmly in focus.

Zoono Group is seeking up to A$1.61 million from a non-renounceable rights issue after completing a separate A$250,000 placement, with its offer document warning of material uncertainty around going concern. The funds are intended to support shelf-life extension projects, intellectual property and working capital, but investors face dilution and an unresolved legal case.

Hydration Pharmaceuticals is asking eligible shareholders for up to A$1.43 million in fresh capital as it funds the next phase of its turnaround. The non-renounceable offer comes with free options, but is neither underwritten nor subject to a minimum subscription.

Eagle Mountain Mining has emerged from FY2026 with no borrowings, a A$7.27 million accounting profit and a funded 20% interest in its Oracle Ridge copper project. The next test is whether Nittetsu’s drilling and earn-in spending can add value to an asset whose mineral resource has not changed since 2023.